Healthcare - Biotechnology - NASDAQ - US
$ 0.0002
0 %
$ 941
Market Cap
0.0
P/E
INCOME STATEMENT
0
REVENUE
-33.8 M
OPERATING INCOME
-35.8 M
NET INCOME
EFFICIENCY
Earnings Waterfall
eFFECTOR Therapeutics, Inc.
| Revenue | 0 |
| Cost Of Revenue | 22.9 M |
| Gross Profit | -22.9 M |
| Operating Expenses | 10.9 M |
| Operating Income | -33.8 M |
| Other Expenses | 1.97 M |
| Net Income | -35.8 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 0 | 3.6 | 1.4 | 42.0 | 0 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 22.9 | 53 K | 24 K | 21.8 | 0.3 |
| Gross Profit | (22.9) | 3.5 | 1.4 | 20.2 | (0.3) |
| OPERATING INCOME | |||||
| Operating Expenses | 10.9 | 32.4 | 31.9 | 26.2 | 28.3 |
| Selling, General and Administrative Expenses | 10.9 | 12.6 | 13.4 | 4.3 | 4.7 |
| Research and Development Expenses | 22.9 | 23.3 | 20.0 | 21.8 | 23.6 |
| Operating Income | (33.8) | (32.4) | (31.9) | 15.8 | (28.6) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | (2.9) | 2.3 | 1.8 | 1.3 | 1.4 |
| Total Other Income | (2.0) | 9.7 | 47.7 | (1.3) | (1.1) |
| Pre-Tax Income | (35.8) | (22.7) | 15.8 | 14.6 | (29.7) |
| NET INCOME | |||||
| Tax Provision | (35.8) | (9.7) | 24 K | 0.4 | 0.1 |
| Net Income | (35.8) | (12.9) | 15.8 | 14.2 | (29.7) |
| EPS | 16.4 | 7.85 | 9.78 | 23.7 | 53.8 |